Global Artificial Pancreas Device System Market report delivers future development strategies, key companies, Possibility of competition, major challenges analysis. The reports elaborate the expansion rate of the Artificial Pancreas Device System market supported the highest company profile analysis. This report providing an in-depth analysis, market size, and evaluation for the developing segment among the industry. Artificial Pancreas Device System Market report will help you take expert decisions, recognize opportunities, plan effective professional tactics, plan new schemes, analyse drivers and restraints and give you a vision on the Artificial Pancreas Device System Market forecast.
The Artificial Pancreas Device System Market report discusses the
primary industry growth drivers and challenges that the vendors and the market
as a whole face and provides an overview of the key trends emerging in the
market. It also talks about the market size of different segments and their
growth aspects along with key leading countries in Americas, Asia-Pacific,
Europe, the Middle East, and Africa regions.
Get Free PDF
Sample (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/artificial-pancreas-device-system-apds-market/request-sample
The pancreas is a part of the human-body that is
responsible for production of multiple hormones such as insulin and glucagon,
along with a few digestive enzymes to allow proper digestion of food items.
Insulin allows body cells to acquire glucose from the blood providing essential
energy for their functioning, at the same time lowering blood glucose levels.
While, glucagon secreted by pancreases is responsible for releasing glucose
that is stored in the liver, raising overall blood glucose levels.
The growing occurrence of diabetes in both - developing
and developed economies is attributed to changing food patterns, inherited
diseases, obesity, physical inactivity and high calorie diet, all leading to
the growth of the artificial pancreas device system industry in recent years.
Moreover, the patient’s over-dependency on insulin, mainly in type 2 diabetes
is key factor for growing demand for artificial pancreas device system.
Other factors such as rise in the awareness among the
patient sab out treatment of diabetes and numerous opportunities for
collaboration between FDA and privately-owned institutions are propelling
growth of the artificial pancreas device system industry in the forecast
period. Though, unavailability of highly skilled healthcare professionals in
underdeveloped countries in African and South American regions is likely to
hamper the growth of the market.
Type 1 diabetes commonly arises due to lower or almost
negligible production of insulin that is needed to regulate blood glucose level
in the body. While, in type 2 diabetes production insulin or already present
insulin is resisted by body itself, causing adverse effects. The artificial
pancreas device system is responsible for closely monitoring the glucose level
by mimicking functionality of a healthy pancreas. The common type of the
artificial pancreas device system utilized by number of diabetes patients these
days are a constant glucose monitoring (CGM) devices and an insulin infusion
pump.
Special types of devices are used such as a blood glucose
devices or glucose meters to regulate the constant glucose monitoring (CGM)
system. A computerized system is implemented in order to manage constant
glucose monitoring (CGM) and insulin infusion pump, providing consistent communication
between the two devices. An artificial pancreas device system is also termed as
a closed-loop system or an automated insulin delivery system. The artificial
pancreas device systems manage glucose level in blood, while regulating or
automatically changing the production of insulin in blood to decrease high
blood glucose levels such as hyperglycemia. The artificial pancreas device
system also monitors and regulate low blood sugar level as required.
The artificial pancreas device system market is divided
by region as North America, Europe, Asia-Pacific, Latin America and Africa.
North America has shown major growth in recent years owing to the rise adoption
of latest technologies in healthcare sector and existence well-established
healthcare infrastructure. Asia-Pacific region is predicted to hold the major
market share in the artificial pancreas device system industry with massive
growth in the forecast period. Countries such as India, China and Singapore are
leading the Asia-Pacific market with the changing food habits, genetic
modification, and growing elderly population.
The key players in the artificial pancreas device
system market are Bigfoot Biomedical Co., Johnson & Johnson Inc., Tandem
Diabetes Care Incorporations, Pancreum, Incorporations, TypeZero Technologies,
and Beta Bionics, Inc.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment